Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ZADITEN EYE DROPS 0.25 mg/ml - HSA Drug Approval Details

Approvals/HSA/ZADITEN EYE DROPS 0.25 mg/ml

Approved

THERAPEUTIC

ZADITEN EYE DROPS 0.25 mg/ml

Excelvision Annonay (FRANCE)🇸🇬 Health Sciences Authority

Approval Date: Feb 25, 2003
Approval ID: 79c3cb98787126df
Company: Excelvision Annonay (FRANCE)
Type: Therapeutic

Approval Details

Approval Id: 79c3cb98787126df
Drug Name: ZADITEN EYE DROPS 0.25 mg/ml
Product Name: ZADITEN EYE DROPS 0.25 mg/ml
Approval Number: SIN12209P
Approval Date: 2003-02-25
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: SOLUTION
Route Of Administration: OPHTHALMIC
Atc Code: S01GX08
Atc Item Name: ketotifen
Pharma Manufacturer Name: NOVARTIS (SINGAPORE) PTE LTD

Active Ingredients

Ketotifen fumarate 0.345mg eqv ketotifen

0.25 mg/ml

Ketotifen fumarate 0.345mg eqv ketotifen

0.25 mg/ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 25, 2003

Approval ID

79c3cb98787126df

Type

Therapeutic

Back to HSA Approvals